CX Aortic Vienna—now less than 4 weeks away!
cxsymposium2020-08-14T16:17:22+01:00Afshin Assadian (Vienna, Austria), current president of the Austrian Society for Vascular Surgery, Alexander Zimmermann (Zurich, Switzerland) and Roberto Chiesa (Milan, Italy) share what to expect from the upcoming CX Aortic Vienna LIVE Virtual Conference, a comprehensive meeting on aortic therapies.
Look ahead to CX Aortic Vienna in September
cxsymposium2020-07-17T16:37:04+01:00Roger Greenhalgh (London, UK) invites you to CX Aortic Vienna, which will run from 8–11 September 2020. The programme will cover open and endovascular aortic interventions from the aortic valve to the iliac arteries. All known pathologies will be included and imaging and diagnostic aspects will be applied systematically […]
CX 2020 LIVE aortic arch discussion highlights importance of underlying pathology and benefit of multidisciplinary team
cxsymposium2020-06-05T17:33:02+01:00
Roger Greenhalgh (top left), Stéphan Haulon (top right), Ludovic Canaud (bottom left), and Gustavo Oderich (bottom right)
This week, the CX 2020 LIVE agenda turned to the technically challenging topic of aortic arch interventions. Through presentations, discussion, and polling, the session—chaired by Roger Greenhalgh (London, UK) and […]
Nearly 70% of CX 2020 LIVE global aortic audience finds type II endoleak without sac expansion harmless
cxsymposium2020-06-02T09:04:25+01:00
Roger Greenhalgh (top left), Ian Loftus (top right), Lindsay Machan (bottom left), and Gustavo Oderich (bottom right)
A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. […]
CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era
cxsymposium2020-06-02T09:11:44+01:00
Chair Roger Greenhalgh (top left), moderator Andrew Holden (top right), Sapan Desai (bottom left), Sabine Steiner (bottom middle), and Misti Malone (bottom right)
CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, […]
CX 2020 is cancelled due to COVID-19
cxsymposium2020-04-21T15:03:24+01:00Dear colleagues,
The CX Symposium team has made the difficult but necessary decision to cancel the Charing Cross Symposium 2020 that was scheduled to take place from 21 to 24 April in London, UK. We will be refunding in full all the registration fees incurred by delegates and will work with our Faculty members to assist […]
Medical device industry leaders call for three big changes to “devastating” EU MDR legislation
cxsymposium2019-11-21T11:56:06+00:00Industry leaders say approximately 50% of all medical devices will be withdrawn from the market; around 30% of manufacturers will not survive and patients might be at risk as a result of the European Medical Device Regulation (EU MDR), which is described by some as the “most disruptive force […]
New MIMICS-2 trial data show helical stents provide durable treatment of diseased femoropopliteal arteries
cxsymposium2019-09-06T16:12:16+01:00
New data from the MIMICS-2 trial show the BioMimics 3D stent, which mimics natural vascular curvature, remains safe and effective for patients with symptomatic atherosclerotic disease of the femoropopliteal arteries two years after implantation.
Principal investigator Timothy Sullivan (Minnesota, USA) presented the two-year findings at this year’s Charing […]
Multicentre dataset reveals the added value of diffusion-weighted imaging in TEVAR practice
cxsymposium2019-09-06T16:13:28+01:00
Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and the future role of diffusion-weighted magnetic resonance imaging (DW-MRI) in reducing stroke from endovascular repair. The multicentre dataset was presented at a Charing […]
Endovascular repair matches open surgery for treatment of men with complex but low-risk aortoiliac disease using self-expanding covered stents
cxsymposium2019-04-18T17:16:33+01:00
Michele Antonello
Endovascular repair shortens hospital stay and has comparable outcomes to open surgery when balloon-expandable covered stents are used to treat low-risk male patients with complex aortoiliac lesions, new data show. Michele Antonello (Padua, Italy), described some of the study’s key results during a presentation at […]
0.018-inch drug delivery platforms are as effective as 0.035-inch devices
cxsymposium2019-09-06T16:14:14+01:00
Andrew Holden
Interventionists can confidently use lower profile drug delivery platforms, based on data that shows 0.018-inch guidewire devices are non-inferior to 0.035-inch guidewires. In a Podium 1st presentation at Charing Cross (CX) Symposium on Thursday, Andrew Holden (Auckland, New Zealand) said: “At 90 days, we can […]
Live case of challenging thoracic endovascular repair demonstrated using virtual reality at CX
cxsymposium2019-11-25T14:50:39+00:00
Tilo Kölbel’s team, led on site in Hamburg, Germany, by Giuseppe Panuccio, successfully performed a thoracic endovascular aortic repair (TEVAR) on a 77-year old female patient with American Stroke Association (ASA) class III, and multiple aortic aneurysm disease with multiple aneurysms. The live case was viewed by […]
Endoanchors add to therapy options for AAA
cxsymposium2019-04-18T10:09:07+01:00
Frank Arko
Using EndoAnchors to fix and seal endovascular aortic grafts is safe and effective for short-neck abdominal aortic aneurysm (AAA) patients, two-year data from the ANCHOR global registry have shown. Frank Arko (Charlotte, USA) presented the findings yesterday at CX Symposium in a podium first session, […]
The impact of paclitaxel concerns on vascular access
cxsymposium2019-04-18T10:32:43+01:00
As part of Wednesday’s CX Vascular Access Workshop in the Pillar Hall Learning Centre, there was a section of the programme on drug-coated balloon trial updates which ended with a panel discussion on whether peripheral vascular disease data is applicable to vascular access. The discussion […]
EVAR with an iliac branch endoprothesis is safe and effective
cxsymposium2019-09-06T16:20:32+01:00
Fabio Verzini
Yesterday, during the Aortic Podium 1st session, Fabio Verzini (Turin, Italy) reported that endovascular aneurysm repair (EVAR) with an iliac branch endoprothesis (Gore) is safe and effective. He added that the procedure was associated with improved quality of life in the short term and […]
Virtual reality stimulates discussion at CX
cxsymposium2019-04-18T10:30:36+01:00
For the first time, the Charing Cross (CX) audience has been able to experience an array of virtual reality live cases in both the peripheral and aortic programmes. The virtual reality live streaming in 360° video, accompanied by a running commentary by the operator, provided a […]
EVAR funding threatened, while strategy for safe, cost-effective repair is “just around the corner”
cxsymposium2019-04-18T09:59:05+01:00
The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the National Institute for Health and Care Excellence (NICE), set to go against widespread endovascular practice in recommending open repair over EVAR. In May […]
Vascular recruitment a “universal problem”: The global perspective
cxsymposium2019-04-18T10:04:27+01:00
Sophie Renton
Across the globe, vascular recruitment is struggling. This was the reason why delegates convened in the Upper Auditorium yesterday afternoon for a CX Highlight Session dedicated to the topic, where representatives from three continents explained exactly how and why the vascular specialty is experiencing this […]
Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE
cxsymposium2020-02-10T11:07:13+00:00
Recorded presentation from CX Symposium 2019
Hence Verhagen, Rotterdam, Netherlands
Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy
cxsymposium2019-09-06T16:25:29+01:00Recorded presentation from CX Symposium 2019
Bijan Modarai, London, United Kingdom
Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR
cxsymposium2019-09-06T16:26:34+01:00Recorded presentation from CX Symposium 2019
Marc Schermerhorn, Boston, United States
While CX audience deems paclitaxel not dangerous, vascular pathologist says establishing “truth takes time”
cxsymposium2019-09-06T16:29:29+01:00
Elena Ladich
Delegates voted overwhelmingly against the notion that there was a demonstrable danger in any organ of the body attributed to circulating paclitaxel. These polling results, with a 67% majority, came after vascular pathologist Elena Ladich (Hollywood, USA) presented insights from new analysis on the effects […]
CX highlights Acute Stroke Challenges
cxsymposium2019-09-06T16:30:22+01:00
On Monday, the 2019 Charing Cross (CX) Symposium opened with the Acute Stroke Challenges programme; the session, which was chaired by Barbara Rantner (Innsbruck, Austria), Hugh Markus (Cambridge, UK) and Ross Naylor (Leicester, UK), featured five CX debates, Hot carotid Challenges, intracranial thrombectomy, and stroke after […]
Ambulatory treatment can be offered to high-risk patients too
cxsymposium2019-09-06T16:31:54+01:00Office-based lower extremity arterial interventions are feasible, safe, and cost-effective, and provide high levels of patient satisfaction. Enrico Ascher (Brooklyn, USA) presented data that “challenges the dogma that high-risk patients should not be offered office-based endovascular infrainguinal arterial procedures”. He was providing a US perspective on ambulatory interventions at CX Symposium 2019.
Ascher cited studies that […]